Letters
Role of comparative efficacy
Drug approvals and size of prescribing pool
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6141 (Published 27 September 2011) Cite this as: BMJ 2011;343:d6141- Garrett Igoe, general practitioner1
- 1Virginia Primary Care, Virginia, Republic of Ireland
- garrett.igoe{at}hse.ie
As a GP with some conscience about the cost to the taxpayer of my prescribing decisions, I found it heartening to read Sorenson and colleagues’ article about the need to measure “comparative efficacy” for European drug approvals.1
In …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.